Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

487
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
487
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

371
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
371
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

145
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
145
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

154
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
154
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-traumatic necrotizing fasciitis caused by Bacillus cereus in a child with acute lymphoblastic leukemia: a case report and proposed gastrointestinal-to-hematogenous pathway.

BMC infectious diseases·2026
Same author

Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study.

BMC palliative care·2026
Same author

Benefit finding and caregiving burden among primary caregivers of patients with advanced cancer in China: A latent profile analysis.

Asia-Pacific journal of oncology nursing·2026
Same author

Trajectory changes of symptom clusters in patients with concurrent chemoradiotherapy for cervical cancer: a prospective longitudinal study.

Frontiers in oncology·2026
Same author

PSMC2 drives tumor progression in nasopharyngeal carcinoma by inhibiting ferroptosis through STAT3.

Discover oncology·2026
Same author

Machine learning-driven multi-objective optimization of Gyroid bioglass scaffolds for site-specific biomechanical adaptation.

Journal of the mechanical behavior of biomedical materials·2026
Same journal

Balanced mediated pathway detection in genomic data.

Statistical applications in genetics and molecular biology·2026
Same journal

Annealed variational mixtures for disease subtyping and biomarker discovery.

Statistical applications in genetics and molecular biology·2026
Same journal

Performance of the permutation test approach with base calling errors for detecting changes in variant allele frequencies in ctDNA for a single patient.

Statistical applications in genetics and molecular biology·2026
Same journal

BLOG: Bayesian longitudinal omics with group constraints.

Statistical applications in genetics and molecular biology·2026
Same journal

AI-driven risk prediction and categorization in cystic fibrosis leveraging AttentiveLSTM and Fox Wolf Optimizer.

Statistical applications in genetics and molecular biology·2026
Same journal

Perfect collinearity not created equal: measuring and visualizing the severity of multi-collinearity of modern omics data.

Statistical applications in genetics and molecular biology·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

2.0K

Biological pathway selection through Bayesian integrative modeling.

Lingling Zheng, Xiao Yan, Sunil Suchindran

    Statistical Applications in Genetics and Molecular Biology
    |June 18, 2014
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel two-level Bayesian model for pathway analysis, integrating multiple microarray datasets to identify biological pathways relevant to specific experimental traits and interventions.

    More Related Videos

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
    05:01

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

    Published on: July 1, 2020

    4.7K
    A Web Tool for Generating High Quality Machine-readable Biological Pathways
    08:01

    A Web Tool for Generating High Quality Machine-readable Biological Pathways

    Published on: February 8, 2017

    21.2K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    2.0K
    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
    05:01

    A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

    Published on: July 1, 2020

    4.7K
    A Web Tool for Generating High Quality Machine-readable Biological Pathways
    08:01

    A Web Tool for Generating High Quality Machine-readable Biological Pathways

    Published on: February 8, 2017

    21.2K

    Area of Science:

    • Bioinformatics
    • Systems Biology
    • Genomics

    Background:

    • Pathway analysis is crucial for understanding gene expression.
    • Existing methods struggle with large, heterogeneous microarray data.
    • Need for flexible methodologies to integrate diverse datasets.

    Purpose of the Study:

    • Develop a novel two-level Bayesian model for integrated pathway analysis.
    • Identify pathways specific to experimental traits and interventions.
    • Generate testable hypotheses from complex biological data.

    Main Methods:

    • A joint Bayesian factor model integrates multiple microarray experiments.
    • Factors are linked to predefined biological pathways.
    • A point mass mixture distribution identifies relevant pathways for each dataset.

    Main Results:

    • The model successfully integrates heterogeneous microarray data.
    • Identified pathways specific to experimental traits and interventions.
    • Novel insights into radiation response in mice peripheral blood.

    Conclusions:

    • The developed model offers a powerful approach for pathway analysis.
    • Enables the identification of context-specific biological pathways.
    • Facilitates hypothesis generation in systems biology research.